Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine versus hemostat powder for bleeding prevention during burn debridement
IRCT20230517058217N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of epinephrine in burn injury (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Amount of bleeding during the operation. Started Sep 2023; status: completed.
02
Drugs
epinephrine
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20230517058217N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230517058217N1.